All Type of News
23 Korean potential biotech companies will gather in event
The Korea Biotechnology Industry Organization(President Jeong-Sun Seo, KoreaBIO) will hold a biotech pipeline investor forum jointly with Mirae Asset Daewoo for a week from the 13th at the Mirae Asset Daewoo headquart...
Pharmas get huge impacts if being careless on ‘Financial Gain and Expenditure Report’
While the ‘Financial Gain and Expenditure Report’ will be implemented January next year, pharmaceutical companies were criticized to have thorough preparations.
This is because they might get in a huge trouble as jud...
Korean OTC drug instructions with low readability
Guideline and instructions written on OTC drugs that the Korean people use reportedly have low readability. Therefore, various improvements were suggested, such as better locations font sizes.
The Dongguk University ...
Seoul and Busan, Ulsan & Gyeonggi Pharmaceutical Associations moving towards invitation for their next chairman
The Seoul District Pharmaceutical Distribution Association and the Busan, Ulsan & Gyeongnam Pharmaceutical Distribution Association would choose their next chairman on their own.
According to the industry concerned o...
Hanmi Pharm’s Olita available for insurance benefits from coming 15th
The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) announced the ‘Drug Insurance Benefits List and Upper Limit Price Table’ had been revised and the Hanmi Pharm’s targeted therapy for non-small cell lun...
“Government must let the medical field know of ways to guarantee profits from the coverage extension plan”
“The government has no choice but to give a higher price than product cost for the medical industry in the process of making a drug insured. People need to know of this.”
Yong-Ik Kim, a former The Minjoo Party repres...
Vemlidy’s active competition in chronic hepatitis B treatment market
Gilead Sciences’ ‘Vemlidy Tab’ has entered general hospitals one after another, which raises an expectation on its sales performance in the future.
‘Vemlidy,’ a Gilead Sciences’ chronic hepatitis B treatment whose he...
Kwang Dong Pharmaceutical signs contract sales agreement of Jeju Samdasoo
Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 9th that it signed a contract sales agreement of Jeju Samdasoo retail products with the Jeju Province Development Co.(President Kyung-Soo Oh) at Sheraton S...
Humira takes over ‘uveitis’ as well with versatility
‘Humira(generic name: adalimumab),’ the most well-known TNF(tumor necrosis factor)-α inhibitor and a chronic immune disorder treatment having 14 Korean indications in Korea, has attracted attention of the industry as ...
MFDS with a high chance of personnel reshuffle for director-level officers and local government chiefs
In order to stabilize the ministry’s organization and avoid confusion, Minister Young-Jin Ryu of Food and Drug Safety is expected to carry out a personnel reshuffle on director-level officers and local government chie...
